Dupilumab Boosts Asthma Control and Lung Function
TOPLINE: Dupilumab reduced airway inflammation and mucus burden and enhanced airway volume and flow, which led to better lung function and improved asthma control in patients with moderate to severe type 2 asthma. METHODOLOGY: Researchers conducted a randomized, phase 4 trial at 72 sites across 14 countries from July 18, 2020, to January 6, 2023, … Read more